583,800 Shares in Omada Health, Inc. $OMDA Bought by Madryn Asset Management LP

Key Points

• Madryn Asset Management LP disclosed a new fourth-quarter position in Omada Health, buying 583,800 shares worth about $9.2 million. The stake represents roughly 1.01% of Omada and is Madryn’s second-largest holding.
• Several other institutions also added to or initiated positions in OMDA, including Sectoral Asset Management, Blue Owl Capital, Main Street Research, Jefferies Financial Group, and Independent Advisor Alliance, signaling broader investor interest.
• Analysts currently view Omada Health as a Moderate Buy, with a consensus price target of $22.91. The stock was up 2.2% to $16.46, and the company recently reported a smaller-than-expected quarterly loss of ($0.05) EPS on revenue of $78.05 million.

Madryn Asset Management LP bought a new position in Omada Health, Inc. (NASDAQ:OMDA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 583,800 shares of the company's stock, valued at approximately $9,212,000. Omada Health comprises 26.5% of Madryn Asset Management LP's holdings, making the stock its 2nd biggest holding. Madryn Asset Management LP owned approximately 1.01% of Omada Health as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. Sectoral Asset Management Inc. raised its position in Omada Health by 32.7% during the fourth quarter. Sectoral Asset Management Inc. now owns 36,500 shares of the company's stock valued at $576,000 after acquiring an additional 9,000 shares in the last quarter. Blue Owl Capital Holdings LP purchased a new position in Omada Health during the fourth quarter valued at approximately $243,000. Main Street Research LLC purchased a new position in Omada Health during the fourth quarter valued at approximately $251,000. Jefferies Financial Group Inc. purchased a new position in Omada Health during the fourth quarter valued at approximately $16,948,000. Finally, Independent Advisor Alliance purchased a new position in Omada Health in the fourth quarter valued at $717,000.

Wall Street Analyst Weigh In

OMDA has been the subject of a number of analyst reports. Wells Fargo & Company upped their price objective on shares of Omada Health from $17.00 to $18.00 and gave the stock an "equal weight" rating in a research report on Friday, May 8th. JPMorgan Chase & Co. decreased their price objective on shares of Omada Health from $32.00 to $26.00 and set an "overweight" rating for the company in a research report on Thursday, March 12th. Evercore reiterated an "outperform" rating and issued a $20.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Citizens Jmp upped their price objective on shares of Omada Health from $18.00 to $21.00 and gave the stock a "market outperform" rating in a research report on Friday, May 8th. Finally, Canaccord Genuity Group set a $24.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Ten research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Omada Health currently has a consensus rating of "Moderate Buy" and an average price target of $22.91.

Omada Health Stock Up 2.2%

OMDA stock opened at $16.46 on Thursday. The stock has a market capitalization of $978.55 million and a P/E ratio of -60.96. The firm has a 50-day simple moving average of $14.25 and a 200-day simple moving average of $14.97. Omada Health, Inc. has a 52 week low of $10.28 and a 52 week high of $28.40.

Omada Health (NASDAQ:OMDA - Get Free Report) last released its earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.08) by $0.03. The business had revenue of $78.05 million during the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. On average, analysts expect that Omada Health, Inc. will post -0.04 earnings per share for the current year.

Insider Transactions at Omada Health

In other news, CEO Sean P. Duffy sold 4,063 shares of the business's stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $14.34, for a total transaction of $58,263.42. Following the completion of the sale, the chief executive officer owned 117,598 shares of the company's stock, valued at $1,686,355.32. The trade was a 3.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Steven L. Cook sold 1,884 shares of the business's stock in a transaction dated Friday, March 13th. The stock was sold at an average price of $13.94, for a total transaction of $26,262.96. Following the sale, the chief financial officer directly owned 200,512 shares of the company's stock, valued at $2,795,137.28. This represents a 0.93% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 8,776 shares of company stock valued at $120,483 over the last 90 days. Corporate insiders own 6.38% of the company's stock.

Omada Health Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

Want to see what other hedge funds are holding OMDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omada Health, Inc. (NASDAQ:OMDA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.